Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 470-280-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25 June 2008 - 07 July 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study has been performed according to OECD and/or EC guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 325740-68-9
- Cas Number:
- 325740-68-9
- IUPAC Name:
- 325740-68-9
- Details on test material:
- - Name of test material (as cited in study report): SPP100 B7
- Substance type: Highly viscous brownish/yellowish oil
- Physical state: liquid
- Analytical purity: 94.9%
- Impurities (identity and concentrations): not indicated
- Composition of test material, percentage of components: not indicated
- Isomers composition: not indicated
- Purity test date: not indicated
- Lot/batch No.: C0031
- Expiration date of the lot/batch: 31 January 2009
- Stability under test conditions:
Stability SPP 100 B7 under storage conditions: Stable
Stability in vehicle Methyl ethyl ketone Not indicated
- Storage condition of test material: At room temperature in the dark
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River France, L’Arbresle Cedex, France.
- Age at study initiation: Approximately 10 weeks.
- Weight at study initiation: 21 to 25 gram (at initiation of treatment).
- Housing: Specific Pathogen Free area (animal room nu.s 18 and 19). Individual housing in Macrolon cages (MI type; height 12.5 cm) containing sterilized sawdust as bedding material (Litalabo, S.P.P.S., Argenteuil, France). Paper (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom) was supplied as cage-enrichment. The paper was removed on Day 1 prior to dosing and was su[lied again after scoring of the ears on Day 3.
- Diet (e.g. ad libitum): Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany).
- Water (e.g. ad libitum): Free access to tap-water.
- Acclimation period: The acclimatization period was at least 5 days before the start of treatment under laboratory conditions.
- Other:
The Mouse, CBA strain, inbred, SPF-Quality, was selected as it is an acceptable animal species to various regulatory authorities as the recommended test system (e.g. OECD, EC, EPA) and background data are available at this facility.
A health inspection was performed prior to treatment, to ensure that the animals are in a good state of health. Special attention was paid to the ears, which were intact and free from any abnormality.
Animals were identified by tail mark with marker pen.
Results of analysis for each batch of diet (nutrients and contaminants), sawdust, paper and water were assessed and did not reveal any findings that were considered to have affected the study integrity. All certificates and results of analysis are retained in the NOTOX archives.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.4 to 23.5° C.
- Humidity (%): 39 to 93%. Temporary deviations from the maximum level of relative humidity (70%) occurred, but laboratory historical data do not indicate an effect of the deviations.
- Air changes (per hr): Approximately 15 per hour.
- Photoperiod (hrs dark / hrs light): Fluorescent light for a 12-hour light/12-hour dark cycle.
IN-LIFE DATES: From: 25 June 2008 To: 07 July 2008
Study design: in vivo (LLNA)
- Vehicle:
- methyl ethyl ketone
- Remarks:
- Merck, Darmstadt, Germany
- Concentration:
- 1 Vehicle: Methyl ethyl ketone
2 10% test item concentration
3 25% test item concentration
4 50% test item concentration - No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: Methyl ethyl ketone (Merck, Darmstadt, Germany) was selected as suitable vehicle based on trial formulations performed at NOTOX and on test substance data supplied by the sponsor.
- Irritation: A preliminary irritation study was conducted in order to select the highest test item concentration to be used in the main study.
A series of two test item concentrations was tested: 25 and 50%. The test system, procedures and techniques were identical to those used during Days 1 to 3 of the main study unless otherwise specified. Two young adult animals were selected (approximately 11 weeks old). Each animal was treated with one concentration on three consecutive days. Approximately 3-4 hours after the last exposure, the irritation of the ears was assessed. In order to facilitate scoring, the ears were cleaned of residual test substance with tap water. Bodyweights were determined on Day 3. The animals were sacrificed after the final observation. No lymph nodes were excised.
- Lymph node proliferation response: Not determined in Preliminary irritation study.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Local Lymph Node Assay
- Criteria used to consider a positive response: DPM values are presented for each animal and for each dose group. A Stimulation Index (SI) is calculated for each group. The SI is the ratio of the DPM/group compared to DPM/vehicle control group.
If the results indicate a SI ≥ 3, the test substance may be regarded as a skin sensitizer, based on the test guideline and recommendations done by ICCVAM (National Institute of Environmental Health Sciences, 1999).
The results were evaluated according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) of the United Nations and the EC criteria for classification and labeling of dangerous substances and preparations (Council Directive 67/548/EEC and all adaptations to technical progress and amendments of this Directive published in the Official Journal of the European Communities).
The EC3 value (the estimated test substance concentration that will give a SI =3) was determined, using linear interpolation (Basketter, 1999).
TREATMENT PREPARATION AND ADMINISTRATION:
Preparation for administration: Formulations (w/w) were prepared within 4 hours prior to dosing and were homogenised to visually acceptable levels. Open epidermal application.
Four groups of five animals were treated with one test item concentration per group. The highest test item concentration was selected from the preliminary irritation study. One group of five animals was treated with vehicle.
Induction - Days 1, 2 and 3
For the experimental animals, the dorsal surface of both ears was epidermally treated (25 μl/ear) with the test item concentration, approximately the same time each day. The concentrations were mixed thoroughly using a vortex mixer immediately prior to dosing. The control animals were treated as described for the experimental animals, except that, instead of the test substance, the vehicle or positive control item was administered.
Treatment - Day 6
Each animal was injected via the tail vein with 0.25 mL of sterile phosphate buffered saline (PBS) (Merck, Darmstadt, Germany) containing 20 μCi of 3H-methyl thymidine (GE Health care, Buckinghamshire, UK).
After approximately five hours, all animals were killed by intraperitoneal injection with pentobarbital Euthesate® (0.2 mL/animal) (Ceva Sante Animale BV, Naaldwijk, The Netherlands). The draining (auricular) lymph node of each ear was excised.
The relative size of the nodes (as compared to normal) was estimated by visual examination and abnormalities of the nodes and surrounding area were recorded. The nodes were pooled for each animal in approximately 3 mL PBS.
Tissue processing for radioactivity – Day 6
A single cell suspension of lymph node cells (LNC) was prepared in PBS by gentle separation through stainless steel gauze (diameter 125 μm). LNC were washed twice with an excess of PBS by centrifugation at 200g for 10 minutes at 4º C. To precipitate the DNA, the LNC were exposed to 5% trichloroacetic acid (TCA) (Merck, Darmstadt, Germany) at 4º C during the night.
Radioactivity measurements – Day 7
Precipitates were recovered by centrifugation, resuspended in 1 mL TCA and transferred to 10 mL of Ultima Gold cocktail (PerkinElmer Life and Analytical Sciences, Boston, MA, US) as the scintillation fluid. Radioactive measurements were performed using a Packard scintillation counter (2800TR). Counting time was to a statistical precision of ± 0.2% or a maximum of 5 minutes whichever comes first. The scintillation counter was programmed to automatically subtract background and convert Counts Per Minute (CPM) to Disintegrations Per Minute (DPM).
In-life examinations: Data collection was performed individually.
Mortality/Viability: Twice daily.
Toxicity: At least once daily.
Body weight: On Days 1 (pre-treatment) and 6.
Irritation of the ears: On Day 3 (3-4 hours after treatment), the skin reactions were assessed. If possible, skin reactions were graded according to the numerical scoring system (see 'Any other information on materials and methods incl. tables). Furthermore, a description of all other (local) effects was recorded.
Food consumption: Subjective appraisal was maintained during the study, but no quantitative investigation introduced.
Water consumption: Subjective appraisal was maintained during the study, but no quantitative investigation introduced. - Positive control substance(s):
- other: The results of a reliability test with Alpha-hexylcinnamicaldehyde, performed not more than 6 months previously, are summarized in the attached document 'Reliability check'.
- Statistics:
- Not performed.
Results and discussion
- Positive control results:
- The six monthly reliability check with Hexylcinnamaldehyde, indicates that the Local Lymph Node Assay as performed at NOTOX is an appropriate model for testing for contact hypersensitivity. (Attached document 'Reliability check')
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: The SI values calculated for the substance concentrations 10, 25 and 50% were 1.0, 1.2 and 4.9 respectively (Figure 1 and Table 4 of attached document 'Figures and tables').
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- Median DPM/animal values are reported due to possible outlier responses for individual animals within groups. Median DPM/animal values for the experimental groups treated with test substance concentrations 10, 25 and 50% were 370, 461 and 1812 respectively. The median DPM/animal value for the vehicle control group was 371. (Tables 3 and 4 of attached document 'Figures and tables')
Any other information on results incl. tables
Preliminary irritation study (Table 1 of attached document 'Figures and tables')
The results of the epidermal exposures for the selection of highest test substance concentration to be tested in the main study are described in the table.
Based on the results, the highest test substance concentration selected for the main study was a 50% concentration
Main Study (Table 2 of attached document 'Figures and tables')
Slight to well-defined erythema of one or both ears was noted in two animals at 10% and all animals at 25 and 50%. No oedema was observed in any of the animals examined. The irritation of the ears as shown by the animals was considered not to have a toxicologically significant effect on the activity of the nodes. The majority of nodes were considered normal in size, except for one or both nodes of four animals at 50% which were considered enlarged in size. No macroscopic abnormalities of the surrounding area were noted.
Body weights and body weight gain of experimental animals remained in the same range as controls over the study period.
No mortality occurred and no symptoms of systemic toxicity were observed in the animals of the main study.
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
- Conclusions:
- The results indicate that the test substance could elicit an SI > 3. The data showed a dose-response and an EC3 value of 37.2% was calculated.
Based on these results:
- according to the recommendations made in the test guidelines, SPP100 B7 would be regarded as skin sensitizer.
- according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) of the United Nations (2007), SPP100 B7 should be classified as skin sensitizer (Category 1).
- according to the EC criteria for classification and labeling requirements for dangerous substances and preparations (Council Directive 67/548/EEC), SPP100 B7 should be labeled as: may cause sensitization by skin contact (R 43).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.